How AI is rewriting the rules of cancer diagnosis with Lucida Medical's Antony Rix

Our guest today is Dr. Antony Rix, founder and CEO of Lucida Medical, an AI-powered prostate cancer diagnostics platform backed in part by Macmillan Cancer Support. In the UK, we diagnose about half of all cancers too late, but we also do hundreds of thousands of biopsies and other tests – and most of these are negative. The problem is that current diagnosis tools can’t always tell aggressive cancer from benign disease with enough certainty. Today, Antony talks about the good and the bad of cancer screening, and how AI could lower patient anxiety if we design it right…